NetScientific subsidiary strikes exclusive licensing deal with AstraZeneca
7th Jun 2021 09:38
(Sharecast News) - Life sciences investment company NetScientific announced on Monday that its subsidiary ProAxsis has entered into an exclusive licensing agreement with AstraZeneca.
Read moreNetScientific's ProAxsis gets grant for Covid-19 project
10th Dec 2020 15:35
(Sharecast News) - Technology commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has been awarded a high impact Innovate UK grant, as part of the recent 'UKRI Ideas to Address Covid-19' competition.
Read moreNetScientific's ProAxsis appoints North American distributor
19th Nov 2020 16:28
(Sharecast News) - Life sciences, technology investment and commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has appointed DiaPharma Group as the exclusive distributor of its portfolio of respiratory research assays for the key North America region.
Read moreNetScientific acquires rest of ProAxsis for £0.23m
16th Oct 2020 09:54
(Sharecast News) - Life sciences and technology commercialisation and investment company NetScientific has agreed to acquire the outstanding minority interest of 43.6% of its portfolio company ProAxsis, it announced on Friday, from QUBIS and the founders.
Read moreNetScientific agrees to acquire EMV Capital and raise £2.3m
5th Aug 2020 09:22
(Sharecast News) - Healthcare intellectual property commercialisation company NetScientific has conditionally agreed to acquire EMV Capital, an investment services company with interests in the industrial high-technology, energy, circular economy, smart city, transportation and healthcare sectors, it announced on Wednesday.
Read moreNetScientific's PDS investment signs deal for Covid-19 vaccine
18th Jun 2020 10:21
(Sharecast News) - NetScientific said one of its portfolio companies had signed a deal to speed up development of a potential Covid-19 vaccine.
Read moreNetScientific CEO stands down to assist with cost reduction efforts
25th Apr 2019 08:48
(Sharecast News) - NetScientific chief executive François Martelet will depart the group on 30 April in order to assist the company in reducing its central costs and to pursue other career opportunities.
Read moreNetScientific clueless as to surge in share price
14th Mar 2019 14:33
(Sharecast News) - NetScientific was forced to respond to the recent skyrocketing of its share price on Thursday, with the board claiming it was not aware of any reason for such movement.
Read moreNo suitors for NetScientific as it suggests delisting
20th Dec 2018 15:02
(Sharecast News) - Healthcare intellectual property commercialisation group NetScientific updated the market on its strategic review on Thursday, which it announced in late November.
Read moreNetScientific's Wanda launches 'CareLink' digital health product
15th Aug 2018 14:43
(Sharecast News) - Transatlantic healthcare IP commercialisation group NetScientific announced on Wednesday that portfolio company Wanda, which it said uses machine learning to help healthcare providers better manage the risk and care of patients, has launched its new digital health application 'Wanda CareLink'.
Read moreNetScientific appoints Google alum Foad Dabiri CEO of Wanda
20th Dec 2016 10:47
(ShareCast News) - Healthcare intellectual property company NetScientific said it had appointed Google alum Foad Dabiri chief executive of its San Francisco-based portfolio company Wanda, with immediate effect. He replaced Steve Curd, who was appointed chief executive in September 2015. Since March
Read moreNetScientific's portfolio companies making progress in H1
27th Sep 2016 15:02
(ShareCast News) - NetScientific, a healthcare company which commercialises intellectual property, reported a wider loss before tax in the first half the year while many of its core portfolio companies have made progress. Loss before tax widened to £6.1m in the six months ended 30 June from £4.3m th
Read moreNetScientific's Vortex Biosciences won licence to four patents from Harvard
3rd Aug 2016 16:11
(ShareCast News) - Biomedical and healthcare technology company NetScientific's portfolio business, Vortex Biosciences, won a license to four patents from Harvard University. The patents cover novel cell electroporation technology (CTC), which Vortex will combine with its CTC enrichment technology t
Read moreNetScientific losses widen as company remains optimistic
7th Apr 2016 15:49
(ShareCast News) - NetScientific's losses widened in 2015, it reported on Thursday, though it was optimistic about the future having completed a radical restructure of its management and portfolio during the 12 months. The AIM-traded transatlantic technology healthcare group made a loss after tax of
Read moreStephen Smith joins NetScientific board
17th Feb 2016 16:17
(ShareCast News) - NetScientific added a big name in the British medical industry to its board on Wednesday, announcing the appointment of Professor Stephen Smith as a non-executive director. The AIM-traded biomedical and healthcare group said Smith had held senior roles in the NHS and academia, inc
Read more